Low-Dose Azacitidine After Allogeneic Stem Cell Transplantation for Acute Leukemia

BACKGROUND: The authors hypothesized that low doses of the hypomethylating agent 5-azacitidine may maximize the graft-versus-leukemia effect and may be tolerated well after allogeneic transplantation (HSCT). METHODS: The drug was given to 17 patients with acute leukemia as salvage for disease recurr...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Jabbour, Elias, Giralt, Sergio, Kantarjian, Hagop, Garcia-Manero, Guillermo, Jagasia, Madan, Kebriaei, Partow, de Padua, Leandro, Shpall, Elizabeth J., Champlin, Richard, de Lima, Marcos
Format: Artigo
Idioma:Inglês
Publicat: 2009
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4086213/
https://ncbi.nlm.nih.gov/pubmed/19235255
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.24198
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars